Clinical Trials List
2023-04-30 - 2026-12-31
Phase I
Recruiting3
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
GILEAD SCIENCES HONG KONG LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shian-Shiang Wang 無
- Chia-Yen Lin 無
- 裘坤元 無
- 林雁婷 無
- Cheng-Kuang Yang 無
- HSIN-CHEN LIN 無
- Chuan-Shu Chen 無
- Cheng-Che Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 徐偉勛 無
- FU-JEN HSUEH 無
- Yu-Chieh Tsai 無
- Ying-Chun Shen 無
- JHE-CYUAN GUO 無
- Jih-Hsiang Lee 無
- 梁逸歆 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
132 participants
